Liquidia Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LQDA research report →
About the company
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.
- CEO
- Roger A. Jeffs
- IPO
- 2018
- Employees
- 170
- HQ
- Morrisville, NC, US
Price Chart
- Market Cap
- $7.02B
- P/E
- 330.11
- P/S
- 24.37
- P/B
- 63.97
- EV/EBITDA
- 129.77
- Div Yield
- 0.00%
- Gross Margin
- 91.78%
- Op Margin
- 15.81%
- Net Margin
- 7.74%
- ROE
- 46.82%
- ROIC
- 12.79%
- Revenue
- $158.32M · 1031.18%
- Net Income
- $-68,924,000 · 47.14%
- EPS
- $-0.80 · 51.81%
- Op Income
- $-51,376,000
- FCF YoY
- 59.32%
- 52W High
- $80.69
- 52W Low
- $11.86
- 50D MA
- $58.83
- 200D MA
- $39.12
- Beta
- 0.59
- Avg Volume
- 1.86M
Get TickerSpark's AI analysis on LQDA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 22, 26 | Bloch Stephen M | sell | 69,500 |
| Jun 22, 26 | Bloch Stephen M | sell | 30,500 |
| Jun 16, 26 | JOHNSON DAVID EDWARD | other | 5,882 |
| Jun 16, 26 | SINGH RAMAN | other | 5,882 |
| Jun 16, 26 | Bloch Stephen M | other | 5,882 |
| Jun 16, 26 | deGoa Damian | other | 5,882 |
| Jun 16, 26 | Horobin Joanna | other | 5,882 |
| Jun 16, 26 | KIRSCH ARTHUR S | other | 5,882 |
| Jun 16, 26 | Rielly-Gauvin Katherine | other | 5,882 |
| Jun 16, 26 | Manning Paul B | other | 5,882 |
Our LQDA coverage
Recent articles, reports, and earnings notes.
No research on LQDA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LQDA report →Similar companies
Peers in the same neighborhood.